Cargando…

Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure

OBJECTIVES: The aim was to investigate the nephroprotective effect of combination of aliskiren (ASK), a direct renin inhibitor and pentoxifylline (PTX), inhibitor of tumor necrotic factor-alpha (TNF-alpha), in rat remnant kidney model of chronic kidney disease (CKD). MATERIALS AND METHODS: Nephrecto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soni, Hitesh M., Patel, Praful P., Patel, Savan, Rath, Akshyaya C., Acharya, Aviseka, Trivedi, Harshkant D., Jain, Mukul R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375824/ https://www.ncbi.nlm.nih.gov/pubmed/25821316 http://dx.doi.org/10.4103/0253-7613.150351

Ejemplares similares

Keishibukuryogan Reduces Renal Injury in the Early Stage of Renal Failure in the Remnant Kidney Model
por: Nakagawa, Takako, et al.
Publicado: (2011)

Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats
por: Soni, Hitesh M., et al.
Publicado: (2014)

Remnant renal volume can predict prognosis of remnant renal function in kidney transplantation donors: a prospective observational study
por: Hori, Shunta, et al.
Publicado: (2021)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Direct Renin Inhibitor: Aliskiren in Chronic Kidney Disease
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008)

Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models
por: Jain, Mukul R, et al.
Publicado: (2015)

Ureteric bud remnant with renal agenesis
por: Chen, Cheng‐Che, et al.
Publicado: (2019)

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
por: Persson, Frederik, et al.
Publicado: (2009)

Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model
por: Nemoto, Yoshikazu, et al.
Publicado: (2019)

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
por: McMurray, John J.V., et al.
Publicado: (2012)

The effect of renal denervation in an experimental model of chronic renal insufficiency, The REmnant kidney Denervation In Pigs study (REDIP study)
por: Lubanda, Jean-Claude, et al.
Publicado: (2017)

Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy
por: Persson, Frederik, et al.
Publicado: (2010)

Iron-Hepcidin Dysmetabolism, Anemia and Renal Hypoxia, Inflammation and Fibrosis in the Remnant Kidney Rat Model
por: Garrido, Patrícia, et al.
Publicado: (2015)

Superselective embolization in management of remnant renal moiety and vessels after radical nephrectomy in horseshoe kidney
por: Sheckley, Fahad, et al.
Publicado: (2021)

Aliskiren: An orally active renin inhibitor
por: Wal, Pranay, et al.
Publicado: (2011)

Aliskiren and the dual complement inhibition concept
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007)

Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet
por: Giri, Suresh R., et al.
Publicado: (2023)

Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
por: Chung, Sungjin, et al.
Publicado: (2017)

Early septic insult in neonatal pigs increases serum and urinary soluble Fas ligand and decreases kidney function without inducing significant renal apoptosis
por: Soni, Hitesh, et al.
Publicado: (2016)

Aliskiren for heart failure: a systematic review and meta-analysis of randomized controlled trials
por: Liu, Hongzhi, et al.
Publicado: (2017)

Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
por: Chung, Sungjin, et al.
Publicado: (2018)

Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release
por: Hu, Shan, et al.
Publicado: (2019)

Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of metalloproteinase-3
por: Nagar, Jignesh K., et al.
Publicado: (2015)

Role of aliskiren in blood pressure control and renoprotection
por: Trimarchi, Hernán
Publicado: (2011)

Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010)

An unusual cause of renal failure; Epstein syndrome
por: Balwani, Manish R, et al.
Publicado: (2015)

N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk
por: Idzerda, Nienke M. A., et al.
Publicado: (2018)

Effect of Hachimijiogan against Renal Dysfunction and Involvement of Hypoxia-Inducible Factor-1α in the Remnant Kidney Model
por: Oka, Hiroshi, et al.
Publicado: (2011)

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
por: Sun, Li, et al.
Publicado: (2017)

Renal denervation for the management of resistant hypertension
por: Patel, Hitesh C, et al.
Publicado: (2015)

An unusual case of “renal failure”
por: Baikunje, S, et al.
Publicado: (2013)

Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells
por: Qiu, Miaojuan, et al.
Publicado: (2018)

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
por: Jain, Mukul R., et al.
Publicado: (2017)

Effect of karanjin on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in Balb/c mice
por: Patel, Praful Prakash, et al.
Publicado: (2017)

Aliskiren in hypertension: evidence for its potential therapeutic value
por: Peter, Doris
Publicado: (2005)

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
por: Ramalho, F. N., et al.
Publicado: (2017)

Renin Inhibition with Aliskiren: A Decade of Clinical Experience
por: Pantzaris, Nikolaos-Dimitrios, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ofo700qd49l66mmhjclq2g2e8c